IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2026 Holdings

Filed 2026-05-15 | 9 holdings | $157.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Innoviva Inc(INVA)COM45781M101$49.7M2,130,95031.5%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$32.3M9,188,63520.5%
Amarin Corp PLC(EH3)SPONSORED ADR023111404$24.2M1,673,39515.3%
Neurocrine Biosciences Inc(NBIX)COM64125C109$15.4M116,5339.7%
Cytokinetics Inc(CYTK)COM NEW23282W605$15.1M228,6239.6%
Lantheus Hldgs Inc(LNTH)COM516544103$12.7M166,9198.0%
Biohaven LTD(BHVN)COMG1110E107$4.8M563,1843.0%
Regeneron Pharmaceuticals(REGN)COM75886F107$3.2M4,1902.1%
VOR Biopharma Inc(VOR)COM NEW929033207$453.1K25,3990.3%